Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Opargo
AddedFeb 16, 2024
UpdatedJun 18, 2026
Opargo

Opargo

Pre-Seed

Opargo: A SaaS platform offering predictive scheduling for healthcare providers to boost revenue.

HQ
Irving, TX, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize healthcare scheduling, Opargo offers a SaaS-based platform designed to optimize revenue for healthcare providers. Their core product, Predictive Scheduler, leverages artificial intelligence and predictive analytics to forecast patient demand, allowing practices to efficiently manage appointments without relying on cancellations and waitlists. Opargo aims to enhance practice management, revenue cycle management, electronic health records, and patient engagement through its innovative technology.

Notable affiliations include integration with the Veradigm Network, which expands Opargo's reach and impact in the healthcare industry. Key achievements include the successful implementation of their predictive scheduling technology across numerous healthcare practices, leading to improved operational efficiency and increased revenue. Overall, Opargo's advanced solutions have significantly contributed to more effective patient care and streamlined administrative processes in the healthcare sector.

Opargo - Similar Companies

CaseCTRL logo

CaseCTRL

casectrl.com

Teambuilder logo

Teambuilder

teambuilder.io

HealthOpX logo

HealthOpX

healthopx.com

Untether Labs logo

Untether Labs

untetherlabs.com

Operating Analytics logo

Operating Analytics

Copient Health logo

Copient Health

copienthealth.com

Sohar Health logo

Sohar Health

soharhealth.com

Doctible logo

Doctible

doctible.com

NexHealth logo

NexHealth

nexhealth.com

Better Healthcare logo

Better Healthcare

Navimize logo

Navimize

navimize.com

AgileMD logo

AgileMD

agilemd.com

Doc-Quick logo

Doc-Quick

Opathica logo

Opathica

BookThatDoc.com logo

BookThatDoc.com

Opargo - Quick Facts

Who are Opargo's competitors?

Companies similar to Opargo include CaseCTRL, Teambuilder, HealthOpX and Untether Labs.

When was Opargo founded?

Opargo was founded in 2013.

Where is Opargo's headquarters located?

Opargo's headquarters is located in Irving, TX, US.

When was Opargo's last funding round?

Opargo's most recent funding round was for $1.1M (USD) in February 2015.

How much has Opargo raised to-date?

As of Feb 17, 2015, Opargo has raised a total of $1.9M (USD).

How many employees does Opargo have?

Opargo has 75 employees as of Feb 5, 2024.

Opargo - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Healthcare Scheduling
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software